Paper300407
Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes.
Namba Y and 2 others. J Immunol, 1977. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes. Papers, record 300407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/300407
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA | Major topic |
| Immunosuppression Therapy | Major topic |
| Lymphocyte Activation | Major topic |
| Lymphokines | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antigens | |
| Cell Adhesion | |
| Cell Division | |
| Concanavalin A | |
| Hydrocortisone | |
| Immunity | |
| In Vitro Techniques | |
| Lymph Nodes | |
| Rats | |
| Rats, Inbred Strains | |
| Spleen | |
| Thymus Gland |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7897257 | Suppressin: an endogenous negative regulator of immune cell activation. | Immunol Res | 1994 | https://conductscience.org/library/papers/7897257 | PubMed |
| 7356693 | Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7356693 | PubMed |
| 6975236 | Further study on the humoral response of a highly-purified spleen-derived immunosuppressive peptide (SDIP). | Immunology | 1981 | https://conductscience.org/library/papers/6975236 | PubMed |
| 6965671 | Cytophotometric, flow cytofluorometric and morphometric demonstration of the existence of an antigen dependent thymus lymphocyte subpopulation. | Histochemistry | 1980 | https://conductscience.org/library/papers/6965671 | PubMed |
| 6682089 | Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors. | Immunology | 1983 | https://conductscience.org/library/papers/6682089 | PubMed |
| 6391655 | In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6391655 | PubMed |
| 6370420 | Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis. | Cancer Metastasis Rev | 1984 | https://conductscience.org/library/papers/6370420 | PubMed |
| 6210637 | Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis. | Infect Immun | 1982 | https://conductscience.org/library/papers/6210637 | PubMed |
| 2461966 | Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2461966 | PubMed |
| 2416868 | A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells. | J Exp Med | 1986 | https://conductscience.org/library/papers/2416868 | PubMed |
| 701474 | Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. | J Clin Invest | 1978 | https://conductscience.org/library/papers/701474 | PubMed |
| 457269 | Influence of malaria infection on the elaboration of soluble mediators by adherent mononuclear cells. | Infect Immun | 1979 | https://conductscience.org/library/papers/457269 | PubMed |
| 314488 | Immuno-suppressive lymphocyte factors. I. Purification of inhibitor of DNA synthesis to homogeneity. | J Exp Med | 1979 | https://conductscience.org/library/papers/314488 | PubMed |
| 203648 | Regulatory substances produced by lymphocytes. VI. Cell cycle specificity of inhibitor of DNA synthesis action in L cells. | J Exp Med | 1978 | https://conductscience.org/library/papers/203648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/300407
GET https://conductscience.org/api/papers/v1/300407/authors